CAR-T Therapy of Multiple Myeloma, Based on the Congresses ASH-2021 and ASCO-2022
Current treatment of multiple myeloma (ММ) based on proteasome inhibitors, immunomodulating drugs, and monoclonal antibodies has, to a certain extent, reached the limit of its potential. Despite considerable clinical advance, ММ still remains a chronic incurable disease. Tumor-specific T-cell therap...
Guardat en:
| Autor principal: | |
|---|---|
| Format: | Artigo |
| Idioma: | Russo |
| Publicat: |
Practical Medicine Publishing House
2023-01-01
|
| Col·lecció: | Клиническая онкогематология |
| Matèries: | |
| Accés en línia: | https://bloodjournal.ru/index.php/coh/article/view/2 |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|